Latest News Archive
Please select Category, Year, and then Month to display items
22 September 2021
|
Story Michelle Nöthling
|
Photo Supplied
Annemarie Le Roux.
“I love working with children.” This is one of the first things Annemarie le Roux mentions when asked to describe herself. This love for children propelled Annemarie into the field of education and she graduated in 2006 with a BEd in Foundation Phase at the UFS. Annemarie immediately immersed herself in the Deaf community, enriching the lives of children at the Thiboloha School for the Deaf in Qwaqwa and the De la Bat School for the Deaf in Worcester.
The academic world enticed Annemarie back to the University of the Free State (UFS) and she was appointed as a junior lecturer in the Department of South African Sign Language (SASL) and Deaf Studies in 2013. Going from strength to strength, Annemarie completed her master’s degree in SASL in 2019, and published an
article earlier this year that she co-wrote with Marga Stander. In this article, they found that SASL “has become an increasingly popular language that hearing university students want to learn as a second language” and subsequently explored different teaching methods used for this emerging group of interested students.
Although now firmly established in academia, Annemarie is still committed to the practical application of SASL. “I am closely involved in student and community engagement through the
SIGNALS Sign Language student association that helps empower the Deaf community and South African Sign Language.” She also interprets for the Deaf community whenever she gets an opportunity, as well as for Deaf students in class and meetings.
On the importance of Sign Language and the recognition of the Deaf community in South Africa, Annemarie believes it will open greater opportunities for development. “More people will be able to learn SASL, and it might even become a subject in school for hearing children.”
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004